Latest Updates
(Year 2024)
UMMC Antimicrobial Guidelines, 3rd Edition (2024) is now available!
(Year 2024)
Please be informed that in line with the decision of the Drugs and Therapeutic (D&T) Sub-Committee Meeting No. 04/2023, the committee has agreed to discontinue the supply of Pravastatin 20mg tablets with immediate effect, once the remaining stock of the medication in the Pharmacy Department has been fully supplied.
Your prompt dissemination of this information to all staff under your supervision is greatly appreciated, and we thank you in advance.
Please be informed that the current supply of Methylene Blue is from a different brand, namely Proveblue 0.5% Injection with different strength and volume. Please refer to the diagram shown:
All categories of staff involved in prescribing, supplying, and handling this medication in their duties must exercise caution to avoid dosing errors.
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
Consequently, all locations holding stock of this medication are requested to return it to the Inpatient Pharmacy, Level 1, Menara Utama, before 25th November 2024.
Your prompt dissemination of this information to all staff under your supervision is greatly appreciated, and we thank you in advance.
Consequently, all locations holding stock of this medication are requested to return it to the Inpatient Pharmacy, Level 1, Menara Utama, before 25th November 2024.
Your prompt dissemination of this information to all staff under your supervision is greatly appreciated, and we thank you in advance.
We appreciate your understanding and cooperation during this period of supply disruption and hope this information is disseminated to all staff under your supervision.
We appreciate your understanding and cooperation during this period of supply disruption.
We are pleased to inform you that Nimodipine 30mg Tablet, which was approved to be included in the UMMC Formulary during the Drug & Therapeutic Committee (D&T) Meeting No. 04/2023, is now available to be prescribed under the following conditions:
Prescriber: Neurosurgery Team
Indication: Subarachnoid haemorrhage
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
We appreciate your understanding and cooperation during this period of supply disruption.
Please be informed that the current supply of Pethidine Injection is from the same brand, namely Demothine Injection, but with different strength and volume. Please refer to the diagram shown:
All categories of staff involved in prescribing, supplying, and handling this medication in their duties must exercise caution to avoid dosing errors.
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
We are pleased to announce that, following discussions by clinical experts in September 2023 regarding adjustments to antihypertensive medications, it has been decided to replace the use of atenolol and carvedilol (at doses exceeding 6.25 mg twice daily) with bisoprolol.
Therefore, the supply of bisoprolol will be effective immediately.
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
In line with the decision from The Drugs & Therapeutics (D&T) Meeting (No. 02/2023), the anti-cholesterol treatment using simvastatin will be replaced with atorvastatin effective immediately upon depletion of the remaining stock.
The following are the updated dose conversion as compared to the earlier recommendation (with reference to SP PPUM: 635/2023 dated December 29, 2023) :-
❗️ Conversion:-Previously : Simvastatin 10mg Once At Night❗️Now : Atorvastatin 10mg Once DailyWe appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
Sulbactam 500mg + Ampicillin 1000mg Injection (with reference to SP PPUM: 418/2024 dated August 13, 2024)
Sodium Tetradecyl Sulfate 3% Injection (with reference to SP PPUM: 453/2024 dated August 29, 2024)
We appreciate your understanding and cooperation during the period of supply disruption.
We appreciate your understanding and cooperation during this period of supply disruption.
Pantoprazole 40mg Injection (with reference to SP PPUM: 302/2024 dated June 11, 2024)
We appreciate your understanding and cooperation during the period of supply disruption.
We appreciate your understanding and cooperation during this period of supply disruption.
With reference to the above matter, please be informed that the Drugs & Therapeutics (D&T) Meeting (No. 02/2023) has agreed to discontinue the supply of Carvedilol 25mg Tablet effective immediately upon depletion of the remaining stock.
The following are the suggested conversion:-
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
With reference to the above matter, please be informed that the Drugs & Therapeutics (D&T) Meeting (No. 02/2022) has agreed to discontinue the supply of Tacrolimus 0.5mg Capsule (Prograf) from the Outpatient Pharmacy effective immediately upon depletion of the remaining stock.
Nephrology Specialists have agreed to use Tacrolimus 0.5mg M/R Capsule (Advagraf) as a replacement for Tacrolimus 0.5mg Capsule (Prograf) under the following criteria:
Supplied to kidney transplant patients recorded in the 'Immunosuppressant 2019' subsidy list of PPUM only.
Patients must be referred to the respective specialist clinic for a prescription switch.
A subsidy fee of RM200.00 will be charged to self-paying patients for a one-month supply.
Patients found unable to tolerate Tacrolimus 0.5mg M/R Capsule (Advagraf) and reverted by the specialist to Tacrolimus 0.5mg Capsule (Prograf) or deemed unsuitable for the switch may purchase Tacrolimus 0.5mg Capsule (Prograf) at full price from PharmUMMC Pharmacy.
New kidney transplant patients and other immunosuppressant treatments using Tacrolimus 0.5mg Capsule (Prograf) may purchase supplies from PharmUMMC Pharmacy.
We appreciate your understanding and cooperation in ensuring that this information is disseminated to all staff under your supervision.
We appreciate your understanding and cooperation during the period of supply disruption.
Ampicillin 500mg injection (with reference to SP PPUM: 039/2024 dated January 26, 2024)
Albumin Human 5% Injection (with reference to SP PPUM: 441/2023 dated September 27, 2023)
We appreciate your understanding and cooperation during the period of supply disruption.
We appreciate your understanding and cooperation during the period of supply disruption.
Potassium Dihydrogen Phosphate 10mmol/10mL Injection (with reference to SP PPUM: 486/2023 dated October 19, 2023)
Factor VIII 250 units Injection (with reference to SP PPUM: 060/2024 dated February 2, 2024)
We appreciate your understanding and cooperation during the period of supply disruption.
Supply Disruption: Brimonidine 0.1% Eye Drops
Expected Resumption: April 2024